Zdrowie i gospodarka · 25/05/2007

FDA Extends Comment Period for Draft Guidance on Complementary and Alternative Medicine Products

The Food and Drug Administration (FDA) is extending the comment period for its draft guidance on complementary and alternative medicine products until May 29, 2007, due to confusion over the closing date for comments on the draft guidance, which originally ended on April 30, 2007.